Although Redx has only been in operation since late-2010, it has already created several valuable drug candidates that are about to begin clinical development. Progress into the clinic will enhance significantly the value of these drug candidates as well as providing further technical validation of the company’s approach. Redx plans to partner these programmes with big pharma for late-stage development and commercialisation. Industry precedent indicates that deal values for clinical sta
08 Aug 2016
Advancing to clinic, increasing value
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Advancing to clinic, increasing value
Redx Pharma Plc (REDX:LON) | 9.2 0 0.0% | Mkt Cap: 36.0m
- Published:
08 Aug 2016 -
Author:
Martin Hall -
Pages:
16
Although Redx has only been in operation since late-2010, it has already created several valuable drug candidates that are about to begin clinical development. Progress into the clinic will enhance significantly the value of these drug candidates as well as providing further technical validation of the company’s approach. Redx plans to partner these programmes with big pharma for late-stage development and commercialisation. Industry precedent indicates that deal values for clinical sta